ARCHIVES

NCI Ends Brash Foray Into the News Business—Emails Tell the Story of the NCI Cancer Bulletin

This article is from The Cancer Letter archive.

Vol. 39 No. 05 | February 1, 2013

Download PDF Visit The Full Archive

Related Articles

Risk of Relapse Continues After Five Years of Therapy

August 29, 2008

In Brief: NCI’s Katz Named Director, Arthritis Institute; Hayden Promoted At Bristol-Myers Squibb

July 14, 1995

The Cancer Letter’s Paul Goldberg Wins Journalism Award

April 10, 2009

DCPC Board Approves Concepts for $28.5 Million Polyp Trial, Other Nutrition Related Studies

May 19, 1989

NCI Advisory Group, Other Cancer Meetings

February 28, 1986

FDA Issues Final Rules On Patient Access To Investigational Drugs

September 11, 2009